The commercial phrase “best BiPAP for COPD” hides several prescriptions. Obstructive-dominant COPD–OSA overlap may use CPAP or auto bilevel. Chronic hypercapnic respiratory failure may require ST or volume-assured home NIV.
Best choices by prescription
| Clinical prescription | HHZ starting choice |
|---|---|
| iVAPS / premium volume-assured NIV | ResMed Lumis 150 |
| Value volume-assured NIV | Home Medix HM-BV-30 |
| ST without volume assurance | ResMed Lumis 100 |
| Lower-cost ST alternative | BMC G3 B30VT |
| Philips AVAPS workflow | DreamStation BiPAP AVAPS |
Why Lumis 150 is the premium choice
Lumis 150 combines iVAPS, intelligent backup-rate behaviour, configurable timing and synchrony, climate control, and a mature ResMed data ecosystem. It is appropriate when the treating team actively manages a ventilation target.
Why HM-BV-30 is the value choice
HM-BV-30 offers TVAPS plus six other PAP/bilevel modes, pressure to 30 cmH₂O, detailed Claro card reports on Windows/macOS, and a three-year/10,000-hour warranty around ₹38,000. Its limitations are the absence of automatic cloud upload and a smaller service footprint.
Do not choose from diagnosis alone
The clinician should review:
- Daytime and overnight CO₂ or surrogate measurements.
- Obstructive events and EPAP requirement.
- Target pressure support or ventilation.
- Backup rate and timing.
- Exacerbation history and treatment goal.
- Oxygen bleed and power-backup plan.
Read the hypercapnic respiratory-failure pathway for the clinical sequence.
Verdict
Lumis 150 is HHZ’s premium COPD home-NIV choice; HM-BV-30 is the value choice. Lumis 100 and BMC G3 fit ST-only prescriptions. The correct commercial shortlist begins only after the clinician identifies whether the patient needs airway splinting, pressure support, backup breaths, or a ventilation target.